世界の細胞治療市場予測 2022-2030年

出版:Inkwood Research(インクウッドリサーチ) 出版年月:2022年10月

GLOBAL CELL THERAPY MARKET FORECAST 2022-2030

Global Cell Therapy Market by Cell Type (Stem Cell (Bone Marrow, Blood, Umbilical Cord-derived Stem Cell, Adipose-derived Stem Cell, Others), Non-stem Cell) Market by Therapy Type (Autologous, Allogeneic) Market by Therapeutic Application (Malignancies, Musculoskeletal Disorders, Autoimmune Disorders, Dermatology, Other Applications) Market by End-user (Hospitals & Clinics, Academic & Research Institutes) By Geography

ページ数 228
価格
シングルユーザライセンス USD 2,500
マルチユーザライセンス USD 3,000
エンタープライズライセンス USD 4,500
種別 英文調査報告書

レポート目次  お問合せ・ご注文  価格・納期について

無料サンプル

KEY FINDINGS
The global cell therapy market is projected to register a CAGR of 14.46% during the forecast period, 2022-2030. The market growth is accredited to the increasing prevalence of chronic disease, thriving regenerative medicine, and rising cellular therapy clinical trials.

The global cell therapy market is projected to register a CAGR of 14.46% during the forecast period, 2022-2030. The market growth is accredited to the increasing prevalence of chronic disease, thriving regenerative medicine, and rising cellular therapy clinical trials.
MARKET INSIGHTS
Cell therapy has a vast range of applications in offering diagnostic/prognostic information during clinical research related to several infectious diseases, cancer, and HIV/AIDS. Also, several factors like the growing population, climate change, and the growing contact between animals and humans have raised the threat of virus outbreaks. Cell therapy replaces dysfunctional or diseased cells with healthy functioning ones. The cells majorly used for such advanced therapies are stem cells, given their ability to differentiate into specific cells needed for repairing defective cells.
Further, cell therapy has applications in the development of regenerative medicine. Additionally, cells like bone marrow and blood cells, embryonic stem cells, adult stem cells, and solid & immature cells are used in cell therapy procedures. Such factors drive the global cell therapy market growth. However, the growing skills gap restricts market growth.
REGIONAL INSIGHTS
The global cell therapy market’s geographical segmentation includes the assessment of Asia-Pacific, Europe, North America, and Rest of World. North America is the largest revenue-generating region in the global market, supplemented by the presence of key players, advanced healthcare infrastructure, robust reimbursement policies, extensive research and development, etc.
COMPETITIVE INSIGHTS
Some of the eminent companies operating in the market include Bristol Myers Squibb Company, Gilead Sciences Inc, Cells for Cells SA, JCR Pharmaceuticals Co Ltd, Anterogen Co Ltd, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

関連市場調査レポート

Inkwood Researchでは下記地域/国別の市場調査レポートも出版しています。各レポートの詳細についてはChosaReport.comまでお問合せください。

  • アジア太平洋地域の細胞治療市場予測 2022-2030年
    ASIA-PACIFIC CELL THERAPY MARKET FORECAST 2022-2030
  • 欧州の細胞治療市場予測 2022-2030年
    EUROPE CELL THERAPY MARKET FORECAST 2022-2030
  • 北米の細胞治療市場予測 2022-2030年
    NORTH AMERICA CELL THERAPY MARKET FORECAST 2022-2030
  • フランスの細胞治療市場予測 2022-2028年
    FRANCE CELL THERAPY MARKET FORECAST 2022-2028

目次

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • KEY DRIVERS
      • INCREASING CELLULAR THERAPY CLINICAL TRIALS
      • GROWTH OF REGENERATIVE MEDICINE
      • HIGH PREVALENCE OF CHRONIC DISEASES
    • KEY RESTRAINTS
      • INCREASING SKILLS GAP
      • HIGH COSTS
  1. KEY ANALYTICS
    • IMPACT OF COVID-19 ON CELL THERAPY MARKET
    • KEY MARKET TRENDS
    • PORTER’S FIVE FORCES ANALYSIS
      • BUYERS POWER
      • SUPPLIERS POWER
      • SUBSTITUTION
      • NEW ENTRANTS
      • INDUSTRY RIVALRY
    • REGULATORY FRAMEWORK
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
  2. MARKET BY CELL TYPE
    • STEM CELL
      • BONE MARROW
      • BLOOD
      • UMBILICAL CORD-DERIVED STEM CELL
      • ADIPOSE-DERIVED STEM CELL
      • OTHERS
    • NON-STEM CELL
  3. MARKET BY THERAPY TYPE
    • AUTOLOGOUS
    • ALLOGENEIC
  4. MARKET BY THERAPEUTIC APPLICATION
    • MALIGNANCIES
    • MUSCULOSKELETAL DISORDERS
    • AUTOIMMUNE DISORDERS
    • DERMATOLOGY
    • OTHER APPLICATIONS
  5. MARKET BY END-USER
    • HOSPITALS & CLINICS
    • ACADEMIC & RESEARCH INSTITUTES
  6. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY DRIVERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    • EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY DRIVERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED KINGDOM
        • GERMANY
        • FRANCE
        • ITALY
        • SPAIN
        • BELGIUM
        • POLAND
        • REST OF EUROPE
    • ASIA-PACIFIC
      • MARKET SIZE & ESTIMATES
      • KEY DRIVERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • SOUTH KOREA
        • THAILAND
        • SINGAPORE
        • AUSTRALIA & NEW ZEALAND
        • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • MARKET SIZE & ESTIMATES
      • KEY DRIVERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • REGIONAL ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA
  1. COMPETITIVE LANDSCAPE
    • KEY STRATEGIC DEVELOPMENTS
      • MERGERS & ACQUISITIONS
      • PRODUCT LAUNCHES & DEVELOPMENTS
      • PARTNERSHIPS & AGREEMENTS
      • BUSINESS EXPANSIONS
    • COMPANY PROFILES
      • ANTEROGEN CO LTD
      • BRISTOL MYERS SQUIBB COMPANY
      • CELLS FOR CELLS SA
      • GILEAD SCIENCES INC
      • JCR PHARMACEUTICALS CO LTD
      • KOLON TISSUEGENE INC
      • MEDIPOST CO LTD
      • MESOBLAST LIMITED
      • NUVASIVE INC
      • SMITH & NEPHEW PLC
      • STEMEDICA CELL TECHNOLOGIES INC
      • VERICEL CORPORATION

LIST OF TABLES  

TABLE 1: MARKET SNAPSHOT – CELL THERAPY

TABLE 2: REGULATORY FRAMEWORK

TABLE 3: GLOBAL CELL THERAPY MARKET, BY CELL TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 4: GLOBAL CELL THERAPY MARKET, BY CELL TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 5: GLOBAL STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 6: GLOBAL STEM CELL MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 7: GLOBAL CELL THERAPY MARKET, BY STEM CELL, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 8: GLOBAL CELL THERAPY MARKET, BY STEM CELL, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 9: GLOBAL BONE MARROW MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 10: GLOBAL BONE MARROW MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 11: GLOBAL BLOOD MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 12: GLOBAL BLOOD MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 13: GLOBAL UMBILICAL CORD-DERIVED STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 14: GLOBAL UMBILICAL CORD-DERIVED STEM CELL MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 15: GLOBAL ADIPOSE-DERIVED STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 16: GLOBAL ADIPOSE-DERIVED STEM CELL MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 17: GLOBAL OTHERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 18: GLOBAL OTHERS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 19: GLOBAL NON-STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 20: GLOBAL NON-STEM CELL MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 21: GLOBAL CELL THERAPY MARKET, BY THERAPY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 22: GLOBAL CELL THERAPY MARKET, BY THERAPY TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 23: GLOBAL AUTOLOGOUS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 24: GLOBAL AUTOLOGOUS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 25: GLOBAL ALLOGENEIC MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 26: GLOBAL ALLOGENEIC MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 27: GLOBAL CELL THERAPY MARKET, BY THERAPEUTIC APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 28: GLOBAL CELL THERAPY MARKET, BY THERAPEUTIC APPLICATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 29: GLOBAL MALIGNANCIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 30: GLOBAL MALIGNANCIES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 31: GLOBAL MUSCULOSKELETAL DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 32: GLOBAL MUSCULOSKELETAL DISORDERS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 33: GLOBAL AUTOIMMUNE DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 34: GLOBAL AUTOIMMUNE DISORDERS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 35: GLOBAL DERMATOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 36: GLOBAL DERMATOLOGY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 37: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 38: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 39: GLOBAL CELL THERAPY MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 40: GLOBAL CELL THERAPY MARKET, BY END-USER, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 41: GLOBAL HOSPITALS & CLINICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 42: GLOBAL HOSPITALS & CLINICS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 43: GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 44: GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 45: GLOBAL CELL THERAPY MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 46: GLOBAL CELL THERAPY MARKET, BY GEOGRAPHY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 47: NORTH AMERICA CELL THERAPY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 48: NORTH AMERICA CELL THERAPY MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 49: KEY PLAYERS IN NORTH AMERICA CELL THERAPY MARKET

TABLE 50: LIST FDA-APPROVED CELL THERAPY PRODUCTS

TABLE 51: EUROPE CELL THERAPY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 52: EUROPE CELL THERAPY MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 53: KEY PLAYERS IN EUROPE CELL THERAPY MARKET

TABLE 54: ASIA-PACIFIC CELL THERAPY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 55: ASIA-PACIFIC CELL THERAPY MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 56: KEY PLAYERS IN ASIA-PACIFIC CELL THERAPY MARKET

TABLE 57: REST OF WORLD CELL THERAPY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 58: REST OF WORLD CELL THERAPY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 59: KEY PLAYERS IN REST OF WORLD CELL THERAPY MARKET

TABLE 60: LIST OF MERGERS & ACQUISITIONS

TABLE 61: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 62: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 63: LIST OF BUSINESS EXPANSIONS

LIST OF FIGURES 

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: GLOBAL CELL THERAPY MARKET, GROWTH POTENTIAL, BY CELL TYPE, IN 2021

FIGURE 6: GLOBAL CELL THERAPY MARKET, BY STEM CELL, 2022-2030 (IN $ MILLION)

FIGURE 7: GLOBAL CELL THERAPY MARKET, GROWTH POTENTIAL, BY STEM CELL, IN 2021

FIGURE 8: GLOBAL CELL THERAPY MARKET, BY BONE MARROW, 2022-2030 (IN $ MILLION)

FIGURE 9: GLOBAL CELL THERAPY MARKET, BY BLOOD, 2022-2030 (IN $ MILLION)

FIGURE 10: GLOBAL CELL THERAPY MARKET, BY UMBILICAL CORD-DERIVED STEM CELL, 2022-2030 (IN $ MILLION)

FIGURE 11: GLOBAL CELL THERAPY MARKET, BY ADIPOSE-DERIVED STEM CELL, 2022-2030 (IN $ MILLION)

FIGURE 12: GLOBAL CELL THERAPY MARKET, BY OTHERS, 2022-2030 (IN $ MILLION)

FIGURE 13: GLOBAL CELL THERAPY MARKET, BY NON-STEM CELL, 2022-2030 (IN $ MILLION)

FIGURE 14: GLOBAL CELL THERAPY MARKET, GROWTH POTENTIAL, BY THERAPY TYPE, IN 2021

FIGURE 15: GLOBAL CELL THERAPY MARKET, BY AUTOLOGOUS, 2022-2030 (IN $ MILLION)

FIGURE 16: GLOBAL CELL THERAPY MARKET, BY ALLOGENEIC, 2022-2030 (IN $ MILLION)

FIGURE 17: GLOBAL CELL THERAPY MARKET, GROWTH POTENTIAL, BY THERAPEUTIC APPLICATION, IN 2021

FIGURE 18: GLOBAL CELL THERAPY MARKET, BY MALIGNANCIES, 2022-2030 (IN $ MILLION)

FIGURE 19: GLOBAL CELL THERAPY MARKET, BY MUSCULOSKELETAL DISORDERS, 2022-2030 (IN $ MILLION)

FIGURE 20: GLOBAL CELL THERAPY MARKET, BY AUTOIMMUNE DISORDERS, 2022-2030 (IN $ MILLION)

FIGURE 21: GLOBAL CELL THERAPY MARKET, BY DERMATOLOGY, 2022-2030 (IN $ MILLION)

FIGURE 22: GLOBAL CELL THERAPY MARKET, BY OTHER APPLICATIONS, 2022-2030 (IN $ MILLION)

FIGURE 23: GLOBAL CELL THERAPY MARKET, GROWTH POTENTIAL, BY END-USER, IN 2021

FIGURE 24: GLOBAL CELL THERAPY MARKET, BY HOSPITALS & CLINICS, 2022-2030 (IN $ MILLION)

FIGURE 25: GLOBAL CELL THERAPY MARKET, BY ACADEMIC & RESEARCH INSTITUTES, 2022-2030 (IN $ MILLION)

FIGURE 26: NORTH AMERICA CELL THERAPY MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

FIGURE 27: UNITED STATES CELL THERAPY MARKET, 2022-2030 (IN $ MILLION)

FIGURE 28: CANADA CELL THERAPY MARKET, 2022-2030 (IN $ MILLION)

FIGURE 29: EUROPE CELL THERAPY MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

FIGURE 30: UNITED KINGDOM CELL THERAPY MARKET, 2022-2030 (IN $ MILLION)

FIGURE 31: GERMANY CELL THERAPY MARKET, 2022-2030 (IN $ MILLION)

FIGURE 32: FRANCE CELL THERAPY MARKET, 2022-2030 (IN $ MILLION)

FIGURE 33: ITALY CELL THERAPY MARKET, 2022-2030 (IN $ MILLION)

FIGURE 34: SPAIN CELL THERAPY MARKET, 2022-2030 (IN $ MILLION)

FIGURE 35: BELGIUM CELL THERAPY MARKET, 2022-2030 (IN $ MILLION)

FIGURE 36: POLAND CELL THERAPY MARKET, 2022-2030 (IN $ MILLION)

FIGURE 37: REST OF EUROPE CELL THERAPY MARKET, 2022-2030 (IN $ MILLION)

FIGURE 38: ASIA-PACIFIC CELL THERAPY MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

FIGURE 39: CHINA CELL THERAPY MARKET, 2022-2030 (IN $ MILLION)

FIGURE 40: JAPAN CELL THERAPY MARKET, 2022-2030 (IN $ MILLION)

FIGURE 41: INDIA CELL THERAPY MARKET, 2022-2030 (IN $ MILLION)

FIGURE 42: SOUTH KOREA CELL THERAPY MARKET, 2022-2030 (IN $ MILLION)

FIGURE 43: THAILAND CELL THERAPY MARKET, 2022-2030 (IN $ MILLION)

FIGURE 44: SINGAPORE CELL THERAPY MARKET, 2022-2030 (IN $ MILLION)

FIGURE 45: AUSTRALIA & NEW ZEALAND CELL THERAPY MARKET, 2022-2030 (IN $ MILLION)

FIGURE 46: REST OF ASIA-PACIFIC CELL THERAPY MARKET, 2022-2030 (IN $ MILLION)

FIGURE 47: REST OF WORLD CELL THERAPY MARKET, REGIONAL OUTLOOK, 2021 & 2030 (IN %)

FIGURE 48: LATIN AMERICA CELL THERAPY MARKET, 2022-2030 (IN $ MILLION)

FIGURE 49: MIDDLE EAST & AFRICA CELL THERAPY MARKET, 2022-2030 (IN $ MILLION)


    お問合せフォーム

    • レポートのタイトルは自動で入ります。
    • *のある項目は必須項目です。

    お名前*

    会社名*

    部署名

    メールアドレス*

    電話番号

    当ウェブサイトを知った経緯を教えてください。

    お問合せ内容

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com